Clinical Trials Update: June 24, 2008
Gastroesophageal Reflux Disease (GERD)
Anxiety Disorders
Psoriasis and Psoriatic Disorders
|
E-mail this article
Subscribe to news
Printer friendly version
|
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Gastroesophageal Reflux Disease (GERD)
If your child is a hospitalized person, aged 17 or younger, and requires acid suppression therapy to treat suspected, symptomatic or proven GERD, the child or adolescent may qualify to participate in this study.
The research site is in Little Rock, Ark.
More information
Please see http://www.centerwatch.com/patient/studies/cat70.html. 
-----
Anxiety Disorders
If you are aged 18 to 50, meet the criteria for generalized anxiety disorder (GAD) as determined by the study doctor, are a non-smoker, and are otherwise in good health, you may qualify for this study.
The research site is in Boston, Mass.
More information
Please see http://www.centerwatch.com/patient/studies/cat14.html.
-----
Psoriasis and Psoriatic Disorders
If you have plaque psoriasis despite at least four months of treatment with etanercept (Enebrel), have psoriatic lesions that have a PGA score greater than 1 at screening, and are aged 18 to 75, you may qualify for this study. Additional criteria apply.
The research site is in Dayton, Wash.
More information
Please see http://www.centerwatch.com/patient/studies/cat126.html.
-----
Copyright 2008 CenterWatch. All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.